Conéctate
Conéctate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Regístrate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Inicio
  2. Acciones
  3. Australia
  4. Australian Stock Exchange
  5. Mayne Pharma Group Limited
  6. Noticias
  7. Otros idiomas
    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Reporte
Diferido Australian Stock Exchange  -  06:10 05/12/2022
0.2100 AUD   -12.50%
02:35Mayne Pharma Group firma un acuerdo de licencia exclusiva para productos de salud femenina y vitaminas prenatales; las acciones caen un 13%.
MT
29/11Transcript : Mayne Pharma Group Limited - Shareholder/Analyst Call
CI
27/10Mayne Pharma Group Limited declara un dividendo especial con franquicia completa, pagadero el 27 de enero de 2023
CI
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivadosFondos 
ResumenTodasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre MAYNE PHARMA GROUP LIMITED
02:35Mayne Pharma Group Signs Exclusive License Deal for Women's Health Products, Prenatal V..
27/11Uitgelicht: laagste koers ooit voor Mithra
27/10Mayne Pharma Group Limited Declares Fully Franked Special Dividend, Payable on 27 Janua..
05/10Mayne pharma completes sale of metrics contract services
04/10Mayne Pharma Completes $475 Million Unit Sale
03/10Catalent, Inc. acquired Metrics, Inc. from Mayne Pharma Group Limited.
29/09Mayne pharma - appointment of chief executive officer and managing director
28/09Mayne Pharma Group Limited Announces Executive Changes Effective from 1 October 2022
28/09Mayne Pharma Group Limited Appoints Mr. Shawn Patrick O'brien as Chief Executive Office..
31/08Mayne pharma group - non-executive director appointment and retirement
31/08Mayne Pharma Group Limited Announces Management Changes
26/08Mayne Pharma Group Widens FY22 Loss
26/08Mayne Pharma Group Limited Reports Earnings Results for the Full Year Ended June 30, 20..
19/08Mayne Pharma Group CEO to Retire
19/08Mayne Pharma : CEO announces plan to retire
19/08Scott Richards Plans to Retire as CEO of Mayne Pharma Group Limited
10/08Catalent to Acquire Metrics Contract Services for $475 Million
10/08Australian Shares Fall Ahead of Release of US Inflation Data
10/08Mayne Pharma Group Sells Metrics Contract Services for $475 Million
10/08Mayne Pharma : announces sale of Metrics Contract Services
09/08Catalent, Inc. agreed to acquire Metrics, Inc. from Mayne Pharma Group Limited for appr..
08/08Les Bourses mondiales en hausse, un oeil sur l'inflation américaine
08/08Mithra krijgt goedkeuring van FDA voor Haloette
08/08Mayne Pharma : and Mithra announce FDA approval of Haloette, a generic version of Nuvaring
08/08Mayne Pharma Secures US FDA Approval for Generic Contraceptive Ring
08/08FDA Grants Approval to Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA of the..
01/08Bel20 lager op eerste handelsdag in augustus
01/08GBL trekt Bel20 in het rood
01/08Mayne pharma and goodrx announce new initiative to increase awareness of nextstellis an..
01/08Celyad uitblinker op rode Brusselse beurs
01/08Brussel licht lager van start
01/08Partner Mithra lanceert campagne voor Nextstellis in VS
29/07Mayne Pharma and Goodrx Announce New Initiative to Increase Awareness of NEXTSTELLIS® a..
27/07Mayne Pharma Group Limited and Mithra Pharmaceuticals - NEXTSTELLIS ORAL CONTRACEPTIVE ..
26/07Bel20 in het rood
26/07Klein verlies in Brussel
26/07Mithra lanceert Nexstellis in Australie
26/07Mayne Pharma's Oral Contraceptive Pills Nextstellis Now Available in Australia
26/07Mayne Pharma Group Limited and Mithra Pharmaceuticals, Sa Announces NEXTSTELLIS Oral Co..
22/07Mayne Pharma : New Chief Financial Officer appointment
22/07Mayne Pharma Names New CFO; Shares Jump 5%
22/07Mayne Pharma Group Limited Announces CFO Changes
27/05Rustige handelsdag na Hemelvaart
26/05Mayne Pharma : Wilsons investor conference presentation
09/05Mayne pharma announced as recipient of $4.8m federal government grant
09/05Mayne Pharma Group Secures $3.4 Million Manufacturing Grant
22/03Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
21/03Mayne Pharma : 22/03/2022 Non Executive Director Appointment
21/03Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group..
21/03Mayne Pharma Group Limited(ASX:MYX) added to S&P/ASX Emer..
28/02Mayne pharma reports 1hfy22 results
25/02Mayne Pharma Group Narrows Loss in Six Monts to December 2021
25/02Degroof Petercam verlaagt koersdoel Mithra licht
24/02Mayne Pharma : 2022 Half Year Investor Presentation
24/02Mayne Pharma : 25/02/2022 Mayne Pharma 2022 Half Year Results Media Release
24/02Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31..
11/02Mayne pharma expands us dermatology portfolio
10/02Mayne Pharma : 10/02/2022 Mayne Pharma expands US dermatology portfolio
10/02Mayne Pharma Group Limited Enters into License and Supply Agreement
10/02Mayne Pharma Expands U.S Dermatology Portfolio
18/01Mayne Pharma - NON-EXECUTIVE DIRECTOR APPOINTMENT AND RETIREMENT
16/01Mayne Pharma : 17/01/2022 Non-Executive Director appointment and retirement
16/01Mayne Pharma Group Limited Announces Management Changes
12/01Mayne Pharma Begins US Distribution of Generic Atopic Dermatitis Ointment
12/01Mayne Pharma : 12/01/2022 Mayne Pharma adds a generic PROTOPIC to US portfolio
11/01Mayne Pharma Group Limited Begins Distribution of Tacrolimus Ointment
04/01Alembic Pharmaceuticals Gets US FDA Final Nod for Doxycycline Hyclate Tablets
2021Mayne Pharma : Change of Director's Interest Notice
2021Mayne Pharma : Notification regarding unquoted securities - MYX
2021Mayne pharma and mithra announce tga approval of nextstellis oral contraceptive
2021Mayne Pharma : Notification of cessation of securities - MYX
2021Breed gedragen herstel in Brussel
2021Brussel overwegend in het groen
2021Bel20 blijft in het groen
2021Bel20 start in het groen na rode vrijdag
2021Australische goedkeuring voor Nextstellis van Mithra
2021Mayne Pharma Secures Australian Regulatory Approval for Oral Contraceptive
2021Mayne Pharma : 29/11/2021 TGA approval of novel oral contraceptive NEXTSTELLIS
2021Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA Announces Therapeutic Goods A..
2021Mayne Pharma : 23/11/2021 2021 AGM CEO's Speech
2021Mayne Pharma : 23/11/2021 2021 AGM Chairman's Address
2021Mayne Pharma : 2021 Mayne Pharma AGM Speeches
2021Mayne Pharma : 23/11/2021 2021 Mayne Pharma AGM Speeches
2021Mayne Pharma : 2021 Corporate Governance Statement and Appendix 4G
2021Brussel zet herstel door
2021Mithra Pharmaceuticals S A : Provides FDA Update on Myring
2021Mayne Pharma : Provides fda update on generic nuvaringo
2021Brussel herstelt alweer
2021Beursblik: lancering Myring van Mithra nog steeds in 2023
2021Lancering Myring van Mithra nog steeds in 2023
2021Scherp hogere opening Bel20 voorzien
2021Mayne Pharma : to Address US FDA Feedback on Generic Version of Birth Contr..
2021Mayne Pharma : 07/10/2021 Mayne Pharma provides FDA update on generic NUVARING
2021Mayne Pharma Provides US Food and Drug Administration Update on Generic NUVARING
2021Mithra is extra uitleg verschuldigd over Myring aan Amerikaanse FDA
2021Bel20 boekt herstel
2021Mithra Pharmaceuticals S A : Announces the Appointment of its Representative to Mayne Phar..
2021Herstel zet door in Brussel
2021Voorzichtige herstel in Brussel
2021Mithra krijgt zitje in bestuur van Mayne Pharma
Próximo evento sobre MAYNE PHARMA GROUP LIMITED